Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Quetiapine may cause hair loss, a side effect not widely recognized before.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Plant-based compounds can improve wound dressings and skin medication delivery.

A woman with lupus had blood cell destruction, treated successfully with medication.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Microneedling may help hair loss, but needs more research.

Hemp seed biomaterials may reduce hair loss and improve hair growth.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

Facial plastic surgeries and aesthetic procedures are becoming more popular in India, with a preference for non-surgical options and effective treatments for facial enhancement and hair loss.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.